Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Businessman Addressing Delegates At Conference

    AAM Annual Meeting Access 2026: Some Highlights

    John Murphy III, CEO of the Association of Accessible Medicines (AAM),...
    Read More
    Businesswoman Managing Company Data Using Analytics Dashboard

    January 2026 Official Monthly Statistics

    We now have official statistics for one-third of FY 2026.  While the...
    Read More
    GDUFA Negotiation - Lachman Blog

    January 21, 2026 GDUFA IV Negotiation Meeting

    On the negotiation front, the FDA and industry continue to feel each o...
    Read More

    From Alignment to Action—Operationalizing AI Under CGMP (Part 3)

    If GMP already accommodates AI, the next challenge is practical execut...
    Read More

    Good AI Practice Meets Timeless CGMP (Part 2)

    The prevailing industry narrative around artificial intelligence (AI) ...
    Read More
    The Shockwave that Hit Biologics - Lachman Blog

    The Shockwave that Hit Biologics, and the Tsunami That Did Not Follow!

    Ever since the FDA issued a Refuse-To-File (RTF) letter to Moderna reg...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today